{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:11:01Z","timestamp":1793506261625,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["ILP-POR-2017-024"],"award-info":[{"award-number":["ILP-POR-2017-024"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"crossref","award":["13\/RC\/2073"],"award-info":[{"award-number":["13\/RC\/2073"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"crossref","award":["16-FRL-3845"],"award-info":[{"award-number":["16-FRL-3845"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/R025096\/1"],"award-info":[{"award-number":["MR\/R025096\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/S009426\/1"],"award-info":[{"award-number":["MR\/S009426\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"crossref","award":["ALGORITM 895134"],"award-info":[{"award-number":["ALGORITM 895134"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mesenchymal stem cell (MSC) derived extracellular vesicles (EVs) have been proposed as an alternative to cell therapy, creating new possible delivery modalities such as nebulisation. We wished to investigate the therapeutic potential of directly nebulised MSC-EVs in the mitigation of <jats:italic>Escherichia<\/jats:italic><jats:italic>coli<\/jats:italic>-induced pneumonia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>EV size, surface markers and miRNA content were assessed pre- and post-nebulisation. BEAS2B and A459 lung cells were exposed to lipopolysaccharide (LPS) and treated with nebulised bone marrow (BM) or umbilical cord (UC) MSC-EVs. Viability assays (MTT) and inflammatory cytokine assays were performed. THP-1 monocytes were stimulated with LPS and nebulised BM- or UC-EVs and phagocytosis activity was measured. For in vivo experiments, mice received LPS intratracheally (IT) followed by BM- or UC-EVs intravenously (IV) and injury markers assessed at 24\u00a0h. Rats were instilled with <jats:italic>E. coli<\/jats:italic> bacteria IT and BM- or UC-EVs delivered IV or by direct nebulisation. At 48\u00a0h, lung damage was assessed by physiological parameters, histology and inflammatory marker presence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MSC-EVs retained their immunomodulatory and wound healing capacity after nebulisation in vitro. EV integrity and content were also preserved. Therapy with IV or nebulised MSC-EVs reduced the severity of LPS-induced lung injury and <jats:italic>E. coli<\/jats:italic>-induced pneumonia by reducing bacterial load and oedema, increasing blood oxygenation and improving lung histological scores. MSC-EV treated animals also showed lower levels of inflammatory cytokines and inflammatory-related markers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MSC-EVs given IV attenuated LPS-induced lung injury, and nebulisation of MSC-EVs did not affect their capacity to attenuate lung injury caused by <jats:italic>E. coli<\/jats:italic> pneumonia, as evidenced by reduction in bacterial load and improved lung physiology.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-023-03385-6","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T19:09:07Z","timestamp":1686078547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Nebulised mesenchymal stem cell derived extracellular vesicles ameliorate E. coli induced pneumonia in a rodent model"],"prefix":"10.1186","volume":"14","author":[{"given":"Hector","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Masterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Sallent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Horan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Elliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Vella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriele","family":"Prina-Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnatas D.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna D.","family":"Krasnodembskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"MacLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Laffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-8711","authenticated-orcid":false,"given":"Daniel","family":"O\u2019Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"issue":"8","key":"3385_CR1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315(8):788\u2013800.","journal-title":"JAMA"},{"issue":"23","key":"3385_CR2","first-page":"2526","volume":"307","author":"TADT Force","year":"2012","unstructured":"ARDS Definition Task Force, Ranieri VM, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526\u201333.","journal-title":"JAMA"},{"issue":"4","key":"3385_CR3","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1378\/chest.119.4.1179","volume":"119","author":"T TenHoor","year":"2001","unstructured":"TenHoor T, Mannino DM, Moss M. Risk factors for ARDS in the United States: analysis of the 1993 National Mortality Followback Study. Chest. 2001;119(4):1179\u201384.","journal-title":"Chest"},{"key":"3385_CR4","doi-asserted-by":"publisher","first-page":"37566","DOI":"10.1038\/srep37566","volume":"6","author":"Y Deng","year":"2016","unstructured":"Deng Y, et al. Umbilical cord-derived mesenchymal stem cells instruct monocytes towards an IL10-producing phenotype by secreting IL6 and HGF. Sci Rep. 2016;6:37566.","journal-title":"Sci Rep"},{"issue":"10","key":"3385_CR5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1164\/rccm.201701-0170OC","volume":"196","author":"TJ Morrison","year":"2017","unstructured":"Morrison TJ, et al. Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med. 2017;196(10):1275\u201386.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"3385_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/thoraxjnl-2015-206813","volume":"70","author":"J Devaney","year":"2015","unstructured":"Devaney J, et al. Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat. Thorax. 2015;70(7):625\u201335.","journal-title":"Thorax"},{"key":"3385_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.imlet.2016.09.009","volume":"179","author":"CM Miao","year":"2016","unstructured":"Miao CM, et al. Bone marrow stromal cells attenuate LPS-induced mouse acute liver injury via the prostaglandin E 2-dependent repression of the NLRP3 inflammasome in Kupffer cells. Immunol Lett. 2016;179:102\u201313.","journal-title":"Immunol Lett"},{"issue":"1","key":"3385_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13287-020-01624-8","volume":"11","author":"S Horie","year":"2020","unstructured":"Horie S, et al. Umbilical cord-derived CD362(+) mesenchymal stromal cells for E. coli pneumonia: impact of dose regimen, passage, cryopreservation, and antibiotic therapy. Stem Cell Res Ther. 2020;11(1):116.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3385_CR9","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1097\/CCM.0000000000002073","volume":"45","author":"GF Curley","year":"2017","unstructured":"Curley GF, et al. Cryopreserved, xeno-free human umbilical cord mesenchymal stromal cells reduce lung injury severity and bacterial burden in rodent escherichia coli-induced acute respiratory distress syndrome. Crit Care Med. 2017;45(2):e202\u201312.","journal-title":"Crit Care Med"},{"issue":"1","key":"3385_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/vsu.12730","volume":"47","author":"W Duan","year":"2018","unstructured":"Duan W, Lopez MJ, Hicok K. Adult multipotent stromal cell cryopreservation: pluses and pitfalls. Vet Surg. 2018;47(1):19\u201329.","journal-title":"Vet Surg"},{"key":"3385_CR11","doi-asserted-by":"crossref","unstructured":"Dutra Silva J et al. Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS. Eur Respir J. 202; 58(1).","DOI":"10.1183\/13993003.02978-2020"},{"issue":"22","key":"3385_CR12","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1089\/scd.2017.0104","volume":"26","author":"V Bunpetch","year":"2017","unstructured":"Bunpetch V, et al. From \u201cbench to bedside\u201d: current advancement on large-scale production of mesenchymal stem cells. Stem Cells Dev. 2017;26(22):1662\u201373.","journal-title":"Stem Cells Dev"},{"issue":"5","key":"3385_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nm.2736","volume":"18","author":"MN Islam","year":"2012","unstructured":"Islam MN, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18(5):759\u201365.","journal-title":"Nat Med"},{"issue":"3","key":"3385_CR14","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.4049\/jimmunol.179.3.1855","volume":"179","author":"N Gupta","year":"2007","unstructured":"Gupta N, et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007;179(3):1855\u201363.","journal-title":"J Immunol"},{"issue":"8","key":"3385_CR15","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/cells9081816","volume":"9","author":"R Guillamat-Prats","year":"2020","unstructured":"Guillamat-Prats R, et al. Alveolar type II cells or mesenchymal stem cells: comparison of two different cell therapies for the treatment of acute lung injury in rats. Cells. 2020;9(8):1816.","journal-title":"Cells"},{"issue":"37","key":"3385_CR16","doi-asserted-by":"publisher","first-page":"11530","DOI":"10.1073\/pnas.1512613112","volume":"112","author":"J Kim","year":"2015","unstructured":"Kim J, et al. Targeted delivery of liquid microvolumes into the lung. Proc Natl Acad Sci U S A. 2015;112(37):11530\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3385_CR17","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s13054-020-03112-0","volume":"24","author":"X Huang","year":"2020","unstructured":"Huang X, et al. Incidence and outcomes of acute respiratory distress syndrome in intensive care units of mainland China: a multicentre prospective longitudinal study. Crit Care. 2020;24(1):515.","journal-title":"Crit Care"},{"issue":"1","key":"3385_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13613-016-0169-x","volume":"6","author":"J Dugernier","year":"2016","unstructured":"Dugernier J, et al. Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized study. Ann Intensive Care. 2016;6(1):73.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"3385_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/1658-354X.197369","volume":"11","author":"HS Mohamed","year":"2017","unstructured":"Mohamed HS, Meguid MM. Effect of nebulized budesonide on respiratory mechanics and oxygenation in acute lung injury\/acute respiratory distress syndrome: randomized controlled study. Saudi J Anaesth. 2017;11(1):9\u201314.","journal-title":"Saudi J Anaesth"},{"issue":"11","key":"3385_CR20","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1160\/TH17-05-0347","volume":"117","author":"L Chimenti","year":"2017","unstructured":"Chimenti L, et al. Nebulized heparin attenuates pulmonary coagulopathy and inflammation through alveolar macrophages in a rat model of acute lung injury. Thromb Haemost. 2017;117(11):2125\u201334.","journal-title":"Thromb Haemost"},{"issue":"3","key":"3385_CR21","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.4049\/jimmunol.168.3.1389","volume":"168","author":"J Cuschieri","year":"2002","unstructured":"Cuschieri J, et al. Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. J Immunol. 2002;168(3):1389\u201396.","journal-title":"J Immunol"},{"issue":"2","key":"3385_CR22","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc7737","volume":"13","author":"Y Sun","year":"2009","unstructured":"Sun Y, et al. Aerosolised surfactant generated by a novel noninvasive apparatus reduced acute lung injury in rats. Crit Care. 2009;13(2):R31.","journal-title":"Crit Care"},{"issue":"3","key":"3385_CR23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/ALN.0000000000002327","volume":"129","author":"C Masterson","year":"2018","unstructured":"Masterson C, et al. Syndecan-2-positive, bone marrow-derived human mesenchymal stromal cells attenuate bacterial-induced acute lung injury and enhance resolution of ventilator-induced lung injury in rats. Anesthesiology. 2018;129(3):502\u201316.","journal-title":"Anesthesiology"},{"issue":"12","key":"3385_CR24","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s11051-013-2101-8","volume":"15","author":"P Hole","year":"2013","unstructured":"Hole P, et al. Interlaboratory comparison of size measurements on nanoparticles using nanoparticle tracking analysis (NTA). J Nanopart Res. 2013;15(12):2101.","journal-title":"J Nanopart Res"},{"key":"3385_CR25","doi-asserted-by":"publisher","first-page":"041002","DOI":"10.1115\/1.4037124","volume":"5","author":"C Maguire","year":"2017","unstructured":"Maguire C, et al. Benchmark of nanoparticle tracking analysis on measuring nanoparticle sizing and concentration. J Micro Nano-Manuf. 2017;5:041002.","journal-title":"J Micro Nano-Manuf"},{"issue":"1","key":"3385_CR26","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"3385_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.05.035","volume":"383","author":"X Yi","year":"2019","unstructured":"Yi X, et al. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3. Exp Cell Res. 2019;383(2): 111454.","journal-title":"Exp Cell Res"},{"issue":"7","key":"3385_CR28","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/stem.2619","volume":"35","author":"XD Tang","year":"2017","unstructured":"Tang XD, et al. Mesenchymal stem cell microvesicles attenuate acute lung injury in mice partly mediated by Ang-1 mRNA. Stem Cells. 2017;35(7):1849\u201359.","journal-title":"Stem Cells"},{"key":"3385_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3389\/fimmu.2017.00401","volume":"8","author":"N Lapko","year":"2017","unstructured":"Lapko N, et al. Long-term monocyte dysfunction after sepsis in humanized mice is related to persisted activation of macrophage-colony stimulation factor (M-CSF) and demethylation of PU.1, and it can be reversed by blocking M-CSF in vitro or by transplanting na\u00efve autologous stem cells in vivo. Front Immunol. 2017;8:401.","journal-title":"Front Immunol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03385-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03385-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03385-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T17:05:16Z","timestamp":1689267916000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03385-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3385"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03385-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"19 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All handling of donor samples and data adhered to the Declaration of Helsinki protocols. BM-MSC production: Mesenchymal stem cells to patients with no option critical limb ischaemia. Galway University Hospital Clinical Research Ethics Committee. Approval 15\/12, 14th December 2016. UC-MSC production: Novel stromal cell therapy for diabetic kindey disease. Galway University Hospital Clinical Research Ethics Committee. Approval 59\/12, 15th May 2019.LPS-induced lung injury mouse model: Stem cell therapy approaches to ARDS therapeutics. Animal Welfare Ethical Review Body of Queen's University Belfast. Approval 2887, 20th April 2020. E. coli induced pneumonia rat model: Assessment of a Nebulised Delivery System for Enhanced Therapeutics for Acute and Chronic Respiratory Disease. Animal Care in Research Ethical Committee of University of Galway. Approval 17-Apr-02, 17th April 2017.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Ms. Emma Horan is a Research Scientist and Dr. Stephen Elliman is Chief Scientific Officer at Orbsen Therapeutics Ltd., Galway Ireland. Dr. Ronan MacLoughlin is Chief Scientific Officer at Aerogen Ltd., Galway, Ireland. No other authors have any conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}